Marine Natural Products with Anticoagulant Activity
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (21 October 2021) | Viewed by 331
Special Issue Editor
Interests: pharmacokinetic/pharmacodynamic modeling and simulation; dose prediction in clinical trials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is with great pleasure that I present the Special Issue of Marine Drugs entitled “Marine Natural Products with Anticoagulant Activity”. Anticoagulants have been used for the treatment of cardiovascular diseases which are related to stroke, angina pectoris, and myocardial infarction. Recently, non-vitamin K antagonist oral anticoagulants (NOACs) such as rivaroxaban and apixaban are being commonly prescribed due to their relative safety compared to warfarin. However, the use of NOACs also results in unintentional adverse events. Therefore, patients still require a better anticoagulant that is not only more potent but also much safer. Natural products could be a promising resource for achieving the appropriate clinical outcomes.
This Special Issue will include novel and sound works from bench to beside, including in vitro and/or in vivo experiments which investigate the anticoagulant activity of natural products originated from marine sources. Reviews, research papers, and short communications will be considered for publication.
We look forward to receiving your valuable contribution to this Special Issue.
Kind regards,
Prof. Dr. Wonku KangGuest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anticoagulants
- marine resources
- in vitro/in vivo experiments
- pharmacokinetics/pharmacodynamics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
